GlassScriptPhysician profile
Nick H Gabriel
NPI 1952351777
$11,526.31
in general payments reported to CMS, 2019-2025
12 companies · $2,647 in 2025
The $2,647 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $1,333 · 2021: $106 · 2022: $3,653 · 2023: $1,550 · 2024: $991 · 2025: $2,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,635 · Food and Beverage: $1,390 · Travel and Lodging: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,635.00 |
| Food and Beverage | $1,390.29 |
| Travel and Lodging | $1,162.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,676.00 | 2019-2025 | |
| Medtronic, INC. | $3,442.02 | 2022-2025 | Signia, Sonicision, Eea |
| Medical Device Business Services, INC. | $803.45 | 2023 | |
| Allergan, INC. | $712.42 | 2019 | |
| Ethicon US, LLC | $279.87 | 2022-2025 | Vistaseal, Linx Reflux Management System, Enseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.35 | 2020-2021 | |
| Intuitive Surgical, INC. | $121.40 | 2019-2021 | |
| Covidien LP | $118.84 | 2019 | |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Acelrx Pharmaceuticals, INC. | $30.21 | 2022 | |
| Molli Surgical (US) INC | $19.57 | 2022 | |
| Smith+Nephew, INC. | $18.18 | 2023 | Pico, Renasys Go V2 Home, Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nick Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.